Dabigatran must be used carefully: literature review and recommendations for management of adverse events
Shan Lin,* Yan Wang,* Lei Zhang, Wei GuanDepartment of Respiratory Medicine, Qinghai University Affiliated Hospital, Xining 810001, People’s Republic of China*These authors contributed equally to this workAbstract: Atrial fibrillation increases the risk of stroke and death. The vitamin-K a...
Saved in:
Main Authors: | Lin S (Author), Wang Y (Author), Zhang L (Author), Guan W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
by: Donaldson M, et al.
Published: (2013) -
Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase
by: Qingxia Zhang, et al.
Published: (2021) -
Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management
by: Zoe Apalla, PhD, et al.
Published: (2021) -
Recommendations for the prevention of adverse events in endotracheal suctioning - integrative review
by: Ana Sabrina Sousa, et al.
Published: (2018) -
The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations
by: E. S. Kropacheva, et al.
Published: (2023)